Duopharma Biotech Keen to Grow Halal Pharmaceutical Exports Targeting the ASEAN Region

Malaysia-based Duopharma Biotech (DB) announced that it will be focusing on the expansion of its Halal portfolio, targeting a higher level of exports (currently contributing 8% of total revenue) to nations with large Muslim populations, such as Indonesia, the Philippines and Thailand, in the Association of Southeast Asian Nations (ASEAN) region. At present, DB exports to 27 countries, including nations in Africa and the Middle East.

According to the Group Managing Director of DB, Leonard Ariff Abdul Shatar, this strategy aims to capitalise on Malaysia’s Global leadership position within the global Halal pharmaceutical market, which is forecast to reach USD 134 billion by 2024.

Become IslamicMarkets.com member

We provide tools that help professionals and institutions steer the global
Islamic economy, unlocking commercial opportunities.

Get more with

• An ecosystem of 500,000+ users
• 50,000+ publications and resources
• Exclusive newsletters and breakthrough stories
• Over 300 industry-led learning modules
• See all benefits >>

Create FREE account or Log in

See all Subscription options

Create FREE account

Unlocking commercial opportunities in the
Islamic economy with:

• An ecosystem of 500,000+ users
• 50,000+ publications and resources
• Latest news, data and insights
• Over 300 industry-led learning modules

Register or Log in

See all Subscription options